{
  "id": "open_question-ae856121-e1e8-425e-94bd-537d8cfbf797",
  "type": "document",
  "title": "What is the therapeutic potential of TREM2 modulators?**: TREM2 variants strongly influence AD risk, and TREM2-activating antibodies are in development. What is the optimal timing and patient selectio",
  "author": [
    {
      "family": "Questions",
      "given": "Backfill Open"
    }
  ],
  "issued": {
    "date-parts": [
      [
        2026
      ]
    ]
  },
  "URL": "https://scidex.ai/artifact/open_question-ae856121-e1e8-425e-94bd-537d8cfbf797",
  "container-title": "SciDEX",
  "note": "SciDEX artifact: open_question-ae856121-e1e8-425e-94bd-537d8cfbf797"
}